The U.S. Food and Drug Administration has awarded Illumina, Inc. of San Diego, Calif., a five-year $17 million contract to develop technology that will provide faster identification of pathogens on produce. Illumina will provide its MiSeq sequencing systems and reagents for conducting whole genome analysis on produce and produce-related environmental salmonella and shigatoxigenic E. coli isolates. FDA currently employs several MiSeq systems and is building its capacity to provide resources and training to enhance whole
» Read more